MAbxience | Finanzwire

Basculer en Français

10663	Companies
227190	Keywords
155586	Articles
120293	Press releases

Home
Companies
MAbxience

BRIEF

published on 12/22/2025 at 22:10, 6 months 7 days ago

FDA Approves mAbxience and Amneal's Denosumab Biosimilars

FDA Approval Amneal Pharmaceuticals Denosumab Biosimilars MAbxience Affordable Biologics
PRESS RELEASE

published on 12/22/2025 at 22:05, 6 months 7 days ago

mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
mAbxience and Amneal announced FDA approval of denosumab biosimilars referencing Prolia and XGEVA, expanding affordable biologic access in the US

FDA Approval Denosumab Biosimilars MAbxience Amneal Prolia XGEVA
BRIEF

published on 12/04/2025 at 09:10, 6 months 26 days ago

MAbxience and HP Collaborate on AI in Biomanufacturing

Artificial Intelligence Biosimilars Biomanufacturing MAbxience HP Inc.
PRESS RELEASE

published on 12/04/2025 at 09:05, 6 months 26 days ago

mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies

AI Solution Biosimilar Development Biomanufacturing MAbxience HP

Accesswire

Published on 06/30/2026 at 18:00, 5 minutes ago

PPX Mining Announces Resumption of Diamond Drilling Program at the Callanquitas Mine
Published on 06/30/2026 at 15:00, 3 hours 5 minutes ago

Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 3 hours 5 minutes ago

BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 3 hours 5 minutes ago

Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 3 hours 35 minutes ago

NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 06/30/2026 at 17:36, 29 minutes ago

YESFLIX Medien GmbH und Your Family Entertainment AG vereinbaren strategische Kooperation
Published on 06/30/2026 at 17:30, 35 minutes ago

Partners Group invests in Avenue Capital Group’s global commercial aviation leasing portfolio
Published on 06/30/2026 at 16:34, 1 hour 30 minutes ago

hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:07, 1 hour 58 minutes ago

RM plc: Holding(s) in Company
Published on 06/30/2026 at 16:05, 1 hour 59 minutes ago

Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis

Les Echos

Published on 06/30/2026 at 17:45, 20 minutes ago

Carrefour completes the sale of Carrefour Romania to Paval Holding
Published on 06/30/2026 at 17:40, 25 minutes ago

Schneider Electric announces agreement to acquire Cognite, unlocking a new level of strategic intelligence for Industrial AI
Published on 06/30/2026 at 07:30, 10 hours 35 minutes ago

Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 10 hours 35 minutes ago

Acquisition of Harwanne Capital Management
Published on 06/30/2026 at 07:00, 11 hours 5 minutes ago

bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens

View all LES ECHOS COMFI WIRE